Opal Wealth Advisors, LLC Astrazeneca PLC Transaction History
Opal Wealth Advisors, LLC
- $325 Million
- Q4 2024
A detailed history of Opal Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 3,683 shares of AZN stock, worth $287,126. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,683
Previous 4,916
25.08%
Holding current value
$287,126
Previous $383,000
37.08%
% of portfolio
0.07%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...